Nivolumab 是PD-1抗体类抑制剂，可用于研究晚期（转移性）非小细胞肺癌。
产品描述
Nivolumab anti-PD-1) is a genetically engineered fully human immunoglobulin Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1PD-1PCD-1) with immune checkpoint inhibitory and antineoplastic activities.
Cas No.
946414-94-4
分子量
146 kDa
